Access a curated library of 300+ synthetic compounds with proven diversity, stability, and synthetic versatility. Complementary high-throughput chemistry capabilities enable rapid production of purified compounds (10-100mg scale) across compatible scaffolds.
This offering provides access to a proprietary library of more than 300 synthetic compounds developed through prior medicinal chemistry efforts. The collection is designed to deliver broad chemical diversity, demonstrated stability, and synthetic versatility, making it a valuable starting point for drug discovery programs, lead optimization campaigns, and scaffold exploration. Beyond the existing library, high-throughput chemistry capabilities are available to produce several hundred additional purified compounds at the 10-100 mg scale, supporting hit-to-lead expansion and focused library generation.
Key features:
The compound library reflects accumulated synthetic efforts with established characterization and demonstrated synthetic accessibility. High-throughput chemistry capabilities are operational and ready to support custom compound production requests. The offering is well-suited for collaborative evaluation, pilot screening, and integration into ongoing discovery programs.
Founded in 1614, the University of Groningen is a comprehensive public research university and among the Netherlands’ largest. Industry ties center on Zernike Campus, a research and technology park that co‑locates institutes with companies, shared labs, and pilot facilities. Clinical translation runs through University Medical Center Groningen, the integrated academic hospital, while the region’s hydrogen ecosystem links partners to major industrial sites. Research is backed by competitive national and European funding. IP & Business Development and Business Generator Groningen provide tech transfer, licensing, startup support and investor access.